Last reviewed · How we verify
platelets rich plasma
At a glance
| Generic name | platelets rich plasma |
|---|---|
| Sponsor | Aya abdelnasser hassani |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial) (NA)
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome (NA)
- Identification of Responders to Platelet-Rich Plasma (PRP) Injections in Lateral Elbow Epicondylalgia
- Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage. (PHASE2)
- Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases (PHASE1, PHASE2)
- Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems (PHASE4)
- Monitoring of Anti-TFPI in Hemophilia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- platelets rich plasma CI brief — competitive landscape report
- platelets rich plasma updates RSS · CI watch RSS
- Aya abdelnasser hassani portfolio CI